Sherlock Biosciences Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
84
- Latest Deal Type
-
M&A
Sherlock Biosciences General Information
Description
Developer of a diagnostic platform designed to control disease in low-resource settings. The company's platform uses engineering biology tools, including CRISPR and synthetic biology to create a new generation of molecular diagnostics, enabling healthcare providers to rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Contact Information
Website
www.sherlock.bio(Operating Subsidiary)
Corporate Office
- 200 Talcott Avenue
- Watertown, MA 02472
- United States
Corporate Office
- 200 Talcott Avenue
- Watertown, MA 02472
- United States
Sherlock Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 19-Dec-2024 | Completed | Generating Revenue | |||
| 6. Grant | 06-Oct-2023 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 28-Feb-2022 | Completed | Generating Revenue | |||
| 4. Grant | 16-Dec-2020 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 23-Apr-2019 | $32.8M | $32.8M | Completed | Startup | |
| 1. Grant | 21-Mar-2019 | $17.5M | Completed | Startup |
Sherlock Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Sherlock Biosciences Comparisons
Industry
Financing
Details
Sherlock Biosciences Competitors (27)
One of Sherlock Biosciences’s 27 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Foundation Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Synthego | Venture Capital-Backed | Redwood City, CA | ||||
| Inscripta | Venture Capital-Backed | Pleasanton, CA | ||||
| Recombinetics | Venture Capital-Backed | Eagan, MN |
Sherlock Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sherlock Biosciences Patents
Sherlock Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023300174-A1 | Ambient temperature nucleic acid amplification and detection | Pending | 01-Jul-2022 | ||
| EP-4377462-A2 | Improved crispr-cas technologies | Pending | 26-Jul-2021 | ||
| CA-3226885-A1 | Improved crispr-cas technologies | Pending | 26-Jul-2021 | ||
| AU-2022319703-A1 | Improved crispr-cas technologies | Pending | 26-Jul-2021 | ||
| CA-3210883-A1 | Nucleic acid amplification using promoter primers | Pending | 09-Feb-2021 | C12Q1/6823 |
Sherlock Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sherlock Biosciences Former Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 10X Capital | Venture Capital | Minority | ||
| A-Level Capital | Venture Capital | Minority | ||
| Albany Capital (Australia) | Venture Capital | Minority | ||
| Baidu Ventures | Corporate Venture Capital | Minority | ||
| Catalio Capital Management | Venture Capital | Minority |
Sherlock Biosciences Acquisitions (1)
Sherlock Biosciences’s most recent deal was a Merger/Acquisition with Sense Biodetection. The deal was made on 01-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sense Biodetection | 01-Feb-2023 | Merger/Acquisition | Diagnostic Equipment |
Sherlock Biosciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sense Biodetection | Abingdon, United Kingdom | 2014 |
Sherlock Biosciences FAQs
-
When was Sherlock Biosciences founded?
Sherlock Biosciences was founded in 2019.
-
Where is Sherlock Biosciences headquartered?
Sherlock Biosciences is headquartered in Watertown, MA.
-
What is the size of Sherlock Biosciences?
Sherlock Biosciences has 84 total employees.
-
What industry is Sherlock Biosciences in?
Sherlock Biosciences’s primary industry is Diagnostic Equipment.
-
Is Sherlock Biosciences a private or public company?
Sherlock Biosciences is a Private company.
-
What is Sherlock Biosciences’s current revenue?
The current revenue for Sherlock Biosciences is .
-
How much funding has Sherlock Biosciences raised over time?
Sherlock Biosciences has raised $113M.
-
Who are Sherlock Biosciences’s investors?
10X Capital, A-Level Capital, Albany Capital (Australia), Baidu Ventures, and Catalio Capital Management are 5 of 18 investors who have invested in Sherlock Biosciences.
-
Who are Sherlock Biosciences’s competitors?
Illumina, Foundation Medicine, Synthego, Inscripta, and Recombinetics are some of the 27 competitors of Sherlock Biosciences.
-
When was Sherlock Biosciences acquired?
Sherlock Biosciences was acquired on 19-Dec-2024.
-
Who acquired Sherlock Biosciences?
Sherlock Biosciences was acquired by Orasure Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
